|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00000102 |
|
Date of registration:
|
03/11/1999 |
|
Primary sponsor: |
|
|
Public title:
|
Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
|
|
Target sample size:
|
|
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00000102 |
|
Study type:
|
Interventional |
|
Study design:
|
Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- diagnosed with Congenital Adrenal Hyperplasia (CAH)
- normal ECG during baseline evaluation
Exclusion Criteria:
- history of liver disease, or elevated liver function tests
- history of cardiovascular disease
Age minimum:
14 Years
Age maximum:
35 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Congenital Adrenal Hyperplasia
|
|
Intervention(s)
|
|
Drug: Nifedipine
|
|
Secondary ID(s)
|
|
M01RR01070
|
|
NCRR-M01RR01070-0506
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|